14 يناير #advanced #Chemotherapy #Docetaxel #first-line #irinotecan #NSCLC #patients #pilot #study Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study by Dr. Fadi Farhat 0
